Femasys Inc. (FEMY) vs Regentis Biomaterials Ltd. (RGNT)

Femasys Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Femasys Inc. is the larger, with a market value of $20.4M against $15.8M — 1.3× the size. Across the 9 metrics below, Regentis Biomaterials Ltd. leads on 7 and Femasys Inc. on 2.

Valuation

Metric FEMY RGNT Medical Instruments & Supplies median
P/E n/m — 34.17
P/S 3.62 — 2.83
P/B 2.07 n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 4.57 n/m 3.06
Earnings yield (142.34%) — (1.84%)
Free cash flow yield (217.10%) 0.00% 0.17%

Profitability

Metric FEMY RGNT Medical Instruments & Supplies median
Gross margin 60.95% — 54.62%
Operating margin (763.90%) — 1.64%
Net margin (534.27%) — 0.00%
Free cash flow margin (786.02%) 0.00% 1.61%
Return on equity (443.65%) 0.00% 0.00%
Return on assets (94.25%) 0.00% 0.00%
Return on invested capital (176.91%) 0.00% 0.00%

Growth

Metric FEMY RGNT Medical Instruments & Supplies median
Revenue growth (TTM) 21.85% — 9.20%
EPS growth (last fiscal year) 44.71% (1,504.65%) —
Revenue growth, 5-year CAGR 17.18% — 9.48%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric FEMY RGNT Medical Instruments & Supplies median
Debt to equity 0.90 0.00 0.08
Current ratio 2.14 5.62 2.49
Net debt to EBITDA 0.23 0.89 0.83

Dividend

Metric FEMY RGNT Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 — 0.00

Size

Metric FEMY RGNT Medical Instruments & Supplies median
Market cap 20.35m 15.82m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack